IJIREM

Abstract

Infection are second leading reason of mortality in individuals with end stages renal diseases, behind cardiovascular disease, and they can cause substantial morbidity in people with chronic kidney disease at an earlier stage. Vaccines are a method of attempting to decrease infection-related morbidity. Although individuals with the CKD or ESRD might not react to immunization and those without renal failures, sufficient seroresponse has been reported with conventional or enhanced influenza, pneumococcus, hepatitis B, or varicella vaccinations. With normal dosage regimens, influenza seems to offer sufficient protection. Despite the fact that some vaccinations are less efficacious in individuals with CKD, there is growing evidence that immunization is beneficial in these groups. Vaccination rates, on the other hand, are low. Given the growing body of data, quality improvement initiatives aimed at improving immunization rate in the patient with all stages of the CKD are required.

Keywords

Disease, influenza, influenza, kidney, vaccinations.

Reference

Edwards KM. Overview of pertussis: Focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005;24(6 SUPPL.):104–8.
Amirfakhryan H. Vaccination against atherosclerosis: An overview. Hell J Cardiol. 2020;61(2):78–91.
Del Giudice G. Vaccination strategies: An overview. Vaccine. 2003;21(SUPPL. 2):83–8.
Ada G. Overview of vaccines and vaccination. Mol Biotechnol. 2005;29(3):255–71.
Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, et al. An overview on the implementation of HPV vaccination in Europe. Hum Vaccin. 2011;7(SUPPL.):128–35.
Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: A critical review. Soc Sci Med. 2014;112:1–11.
Kausz AT, Gilbertson DT. Overview of Vaccination in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2006;13(3):209–14.
Buddle BM, Parlane NA, Wedlock DN, Heiser A. Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans. Transbound Emerg Dis. 2013;60(SUPPL1):136–46.
Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: A historical overview. Vaccine. 2008;26(49):6266–73.

Cites this article as

[Namrata Arya , Krishna Raj Singh (2022), Vaccination in Chronic Kidney Disease: An Overview, International Journal of Innovative Research in Engineering & Management (IJIREM), Vol-9, Issue-1, Page No-157-160], (ISSN 2347 - 5552). www.ijirem.org